The University of Miami Health System, for example, recently opened a medical center in Doral, HCA Florida Healthcare has ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

New York City-based The Icahn School of Medicine at Mount Sinai has established a new research center focused on using AI to ...

The Center for AI in Children’s Health underscores Mount Sinai’s commitment to pioneering AI-driven technologies.

More than 100 students at the Renaissance School of Medicine found out on Friday which hospital they'd be assigned to.

The Icahn School of Medicine at Mount Sinai has launched the Center for Artificial Intelligence in Children’s Health. Photo courtesy ...

The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...

Glicksberg, PhD, an expert in digital health and clinical informatics, will lead the Center for Artificial Intelligence (AI) ...

The Icahn School of Medicine at Mount Sinai has launched the Center for Artificial Intelligence (AI) in Children's Health, ...

New York City-based Mount Sinai Health System has launched the Center for Artificial Intelligence in Children’s Health to ...

Emma Young, MS, and Avner Schlessinger, PhD, conduct structural analysis of a novel drug target at the AI Small Molecule Drug Discovery Center at the Icahn School of Medicine at Mount Sinai.

The Center will develop AI-powered solutions ... and real-time monitoring at Mount Sinai Kravis Children’s Hospital. Advancing personalized medicine through multi-omics research, rare disease ...